Table 2.
CD134+ | CD137+ | GITR+ | CD3+ CD25+ | CD95+ | HLA-DR+ | CD69+ | ||
---|---|---|---|---|---|---|---|---|
Media | TD | 1 (0.4–1.8) | 0.9 (0.5–1.5) | 1.2 (0.9–1.7) | 4.3 (3.3–5.6) | 9.1 (6.4–12.6) | 1.1 (0.5–2.5) | 1.9 (1.5–2.4) |
ASD | 0.8 (0.4–1.0) | 0.7 (0.3–1.5) | 0.6+ (0.4–1.0) | 3.5 (2.2–5.2) | 9.5 (8.0–16.0) | 0.9 (0.7–2.1) | 2.1 (1.3–2.7) | |
PHA | TD | 10 (6.7–27.9) | 26.2 (21.0–29.9) | 6 (3.2–8.6) | 45.7 (31.5–56.9) | 10 (4.7–22.4) | 4.1 (2.6–5.7) | 34.4 (21.3–42.2) |
ASD | 5.4* (2.4–12.4) | 25.7 (15.8–37.1) | 5.6 (2.8–10.3) | 32.4* (19.4–49.4) | 13.1 (4.5–21.1) | 5 (3.0–6.2) | 33.3 (29.4–36.4) |
Data are presented as median and interquartile ranges.
p<0.05 unstimulated (media alone) levels in ASD children compared with unstimulated levels in typically developing controls.
p<0.05 stimulated responses in ASD children compared with stimulated responses in typically developing controls.